1675248-19-7: Tofacitinib Amide Impurity
Tofacitinib Amide Impurity (CAS No: 1675248-19-7) Or 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide, Tofacitinib Amide is an impurity of Tofacitinib, Tofacitinib is JAK inhibitor, application for the treatment of several diseases, such as inflammatory bowel disease, rheumatoid arthritis, and psoriasis.
Additional information on CAS 1675248-19-7
VE008141
1675248-19-7
C16H22N6O2
330.38 g/mol
Tofacitinib
3-((3R, 4R)-4-Methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
N/A
Sci-Hub, Metabolic activation of tofacitinib mediated by myeloperoxidase in vitro, 10.1021/acs.chemrestox.9b00280. (2019). Retrieved January 29, 2022, from Sci-hub.ee website: https://sci-hub.ee/10.1021/acs.chemrestox.9b00280 ?
In-stock
Other products related to tofacitinib
CAS No. | Name of Impurity | Parent Drug | Catalogue No. |
---|